Scars and Keloids Treatment
Scars and Keloids Treatment
Treatment for a scar is decided by two questions asked before any technique is discussed: which kind of scar this is, and where it sits on its own timeline. A hypertrophic scar that is still remodelling is supported with measures that reduce tension and is given time, because it is still moving in the right direction on its own. A keloid is treated actively, because it will not settle, and it is treated with more than one measure, because the process that produced it is still running. A contracture is treated for function rather than for appearance, since the problem is a movement that cannot be made or an eyelid that will not close. And a scar that has finished maturing is treated for whichever property the patient wants changed — height, colour, firmness, surface or tightness. The sequence runs from the least invasive measure that could work to the most, and the reason is not caution for its own sake: in this condition the more aggressive options are the ones that can leave a worse scar than the one being treated.
Two questions before any technique
The same scar can be treated in several ways, and which of them is appropriate depends on answers that are established first:
- Which kind is it, because the keloid is the exception. For most scars, an operation is a reasonable first option. For a keloid it is not, because the operation is itself a new wound in skin that has already demonstrated how it responds to injury, and removal on its own carries a high chance of recurrence. In a keloid the plan attaches an adjuvant measure to the operation or avoids the operation altogether.
- How mature it is, because the timing decides the outcome. A scar that is still remodelling is still changing shape, colour and firmness on its own. Operating during that phase removes tissue that is only part of the problem and creates a new wound in skin that is actively laying down collagen, which is why a scar that is still settling is usually treated non-surgically and reviewed.
- What the target is, because function and appearance are treated differently. A scar that restricts a joint or prevents an eyelid from closing is treated for the movement or the closure; a scar that is settled and conspicuous is treated for how it looks. The measures overlap, and the purpose and the way the result is judged do not.
Why the order of the questions matters. Asking which kind of scar this is before asking what can be done prevents the commonest error in this condition — treating a keloid as though it were a scar and removing it, then meeting it again, larger, months later.
The non-surgical measures
These are the measures that do not involve an operation, and for a scar that is still maturing they are the appropriate first step:
- Silicone, in sheet or gel form, worn over the scar for several hours a day and continued for months. It is the standard first-line measure for a raised or active scar, and it works by keeping the surface hydrated and under a degree of pressure and occlusion rather than by any active ingredient. It requires consistency, and its benefit accumulates over months rather than weeks.
- Pressure, delivered through a garment or a shaped device. Applied continuously over a long period, pressure is an established measure particularly after burns and for scars over a large area. It depends on the device fitting well and on the surface allowing it to be worn.
- Reduction of tension across the scar. This is the measure with the clearest rationale, since tension is the strongest known local driver of how a scar behaves. It includes how a wound was closed, support applied to the site afterwards, and — in the patient’s own hands — avoiding the movements that pull on the repair while it is still fresh.
- Laser treatment. Lasers are used to reduce redness, to soften a scar, and to improve the surface and the texture. They change those properties rather than removing the scar, and more than one session is usually needed.
Why these come first where they can. Because they are reversible, they can be combined with everything else, and they do not create a new wound. Where a scar is still maturing, they are also acting on tissue that is already moving in the right direction, which makes them a good use of the time it takes to settle.
Injections into the scar
Injecting a substance directly into scar tissue is the mainstay of treatment for a raised scar that is not settling, and for a keloid:
- Corticosteroid, injected into the scar itself. It softens and flattens the tissue and frequently relieves the itch, and it is given at intervals over a course rather than as a single treatment. The number of doses is deliberately limited, because repeated injection has its own effects on the skin, including thinning and small visible vessels.
- Fluorouracil, alone or combined with a corticosteroid. Used particularly where a keloid has not responded adequately to steroid alone, and given into the scar in the same way.
- Cryotherapy, which freezes the tissue to reduce its bulk. It is used most often for smaller keloids and is frequently combined with an injection in the same session, since the two act on the scar in different ways.
What to expect from a course of injections. Change is gradual and measured over months rather than days; itch often improves before the scar looks noticeably flatter; and the effect depends on continuing the schedule rather than attending once. Because the injections act on the scar and not on the tendency of the skin to form it, a keloid that responds can still recur afterwards, which is why the plan states what would be done if it does.
Why an operation on a keloid is planned differently
This is the single most important practical point in the treatment of keloids, and it is worth stating as plainly as possible:
- Removing a keloid on its own has a high chance of recurrence. The excision produces a new wound in skin that has already shown that it responds to injury by producing this tissue. The result can be a keloid larger than the one that was removed, which is why simple excision is not the standard treatment.
- An operation is therefore planned with an adjuvant attached to it. That may be an injection into the healing scar, pressure, silicone, or a course of radiotherapy directed at the site — each of which lowers the chance of recurrence without eliminating it. The adjuvant is part of the operation, not an optional extra.
- Where the operation is appropriate at all, it is usually for a specific reason. A keloid that is large and disabling, one that has not responded to non-surgical measures, or one in a site where a smaller result is worth the risk. The decision is made case by case, and it is a decision about proportions rather than about removal.
Why an operation is not withheld on principle. Surgery has a real place in the treatment of a keloid, and there are keloids for which it is the most useful thing that can be offered. What the assessment adds is the arrangement around it — which adjuvant, in what order, judged against what — so that the operation is one part of a plan rather than a standalone attempt.
When the problem is movement rather than appearance
A scar that crosses a joint or a free margin is a different problem, and it is treated for a different purpose:
- Releasing a contracture, with resurfacing. An operation divides the tissue that is shortening and then covers the defect with a skin graft or a flap. What is being restored is movement — a finger that straightens, an arm that lifts, a mouth that opens — and success is measured in the range regained.
- An eyelid that cannot close is treated without waiting. Where a scar prevents the lid from covering the eye, the surface is left exposed and the eye itself is at risk. That situation is a functional indication and is dealt with on that basis rather than deferred while other measures are tried.
- In children, the timing carries its own reasoning. A scar crossing a joint in a growing child can limit the growth of the tissue around it as well as the movement, and a release may need to be planned with the growth in mind rather than as a single definitive procedure.
Why this is separated from the cosmetic discussion. It is separated because the aim is different, the urgency is sometimes different, and the way the result is judged is different. A patient who has been offered a release with resurfacing should understand that the target is the movement, and that the appearance afterwards is a consequence of covering the defect rather than the point of the operation.
How the sequence is decided
The plan states an order rather than a menu, and the order follows a small number of rules:
- Least invasive first, where it could work. Silicone, pressure and tension reduction cost little and can be combined with anything that follows. An operation forecloses options and adds a new wound, so it is placed later unless there is a reason to move it forward.
- Function before appearance. Where a scar restricts movement or eyelid closure, that is dealt with first, because the consequence of waiting is worse and because the treatment for it is not interchangeable with the treatment for appearance.
- One target at a time in a patient with several scars. Where keloids are multiple, treating all of them at once makes it impossible to tell what worked, and it multiplies the number of new wounds created at the same time. A sequence allows each measure to be judged.
- Every step is judged against a record taken at the start. The severity and symptoms written down at the first visit are what make the response to a measure visible; without them, the next decision rests on an impression.
What the plan should say before it ends. Which measure comes first and why, how long it should be given before it is judged, what improvement would look like, and what the next step would be if it is not enough. A scar is treated over months, and a plan that stops at the first measure leaves the patient without a description of the journey.